{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for abametapir in Reference Text / Citation (approximate match)
Showing 1 - 1 of 1 results
Status:
US Previously Marketed
Source:
XEGLYZE by HATCHTECH
(2020)
Source URL:
First approved in 2020
Source:
XEGLYZE by HATCHTECH
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Hatchtech is developing abametapir, an organic heterocyclic small-molecule, for the treatment of pediculosis (head lice). Abametapir is an inhibitor of metalloproteinases critical for louse survival and egg development. Abametapir lotion, 0.74%, demonstrated significant ovicidal activity against head lice eggs with a single application.
